These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1711944)

  • 1. Growth retardation in juvenile chronic arthritis patients treated with steroids.
    Falcini F; Taccetti G; Trapani S; Tafi L; Volpi M
    Clin Exp Rheumatol; 1991; 9 Suppl 6():37-40. PubMed ID: 1711944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth retardation in non-steroid treated juvenile rheumatoid arthritis.
    Polito C; Strano CG; Olivieri AN; Alessio M; Iammarrone CS; Todisco N; Papale MR
    Scand J Rheumatol; 1997; 26(2):99-103. PubMed ID: 9137323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and complications of chronic iridocyclitis in ANA-positive pauciarticular juvenile chronic arthritis.
    Gori S; Broglia AM; Ravelli A; Aramini L; Di Fuccia G; Nicola CA; Martini A
    Int Ophthalmol; 1994-1995; 18(4):225-8. PubMed ID: 7797387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-articular steroids in pauciarticular juvenile chronic arthritis, type 1.
    Hertzberger-ten Cate R; de Vries-van der Vlugt BC; van Suijlekom-Smit LW; Cats A
    Eur J Pediatr; 1991 Jan; 150(3):170-2. PubMed ID: 2044586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis.
    Breit W; Frosch M; Meyer U; Heinecke A; Ganser G
    J Rheumatol; 2000 Nov; 27(11):2696-702. PubMed ID: 11093456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final height, armspan, subischial leg length and body proportions in juvenile chronic arthritis. A long-term follow-up study.
    Zak M; Müller J; Karup Pedersen F
    Horm Res; 1999; 52(2):80-5. PubMed ID: 10681637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic juvenile chronic arthritis].
    Boven K; Kerkhof A; Kuis W
    Tijdschr Kindergeneeskd; 1991 Oct; 59(5):153-7. PubMed ID: 1720263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral metabolism in juvenile chronic arthritis: the influence of steroids.
    Bardare M; Bianchi ML; Furia M; Gandolini GG; Cohen E; Montesano A
    Clin Exp Rheumatol; 1991; 9 Suppl 6():29-31. PubMed ID: 2060174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition.
    Touati G; Prieur AM; Ruiz JC; Noel M; Czernichow P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):403-9. PubMed ID: 9467548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deflazacort.
    Joshi N; Rajeshwari K
    J Postgrad Med; 2009; 55(4):296-300. PubMed ID: 20083885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular complications in juvenile chronic arthritis (JCA).
    Galea P; D'amato B; Goel KM
    Scott Med J; 1985 Jul; 30(3):164-7. PubMed ID: 3877342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis.
    De Benedetti F; Robbioni P; Massa M; Viola S; Albani S; Martini A
    Clin Exp Rheumatol; 1992; 10(5):493-8. PubMed ID: 1458703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
    Balsan S; Stéru D; Bourdeau A; Grimberg R; Lenoir G
    Calcif Tissue Int; 1987 Jun; 40(6):303-9. PubMed ID: 3111667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile chronic arthritis in urban San José, Costa Rica: a 2 year prospective study.
    Arguedas O; Fasth A; Andersson-Gäre B; Porras O
    J Rheumatol; 1998 Sep; 25(9):1844-50. PubMed ID: 9733470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
    Markham A; Bryson HM
    Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG-anti-IgG antibodies in juvenile chronic arthritis.
    Schlump U; Howard A; Ansell BM
    Scand J Rheumatol; 1985; 14(1):65-8. PubMed ID: 3873694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statural growth and skeletal maturation in rheumatic prepubertal children treated with a third generation glucocorticoid (deflazacort) versus prednisone. An interim study.
    Vignolo M; Milani S; Imbimbo B; Naselli A; Di Battista E; Piaggio G; Leveratto L; Morreale G; Sardella ML; Corsini M
    Clin Exp Rheumatol; 1991; 9 Suppl 6():41-5. PubMed ID: 2060177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.
    Varbanova BB; Dyankov ED
    Adv Exp Med Biol; 1999; 455():331-6. PubMed ID: 10599365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
    Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
    Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarticular triamcinolone hexacetonide injection in children with chronic arthritis: a survey of clinical practice.
    Yang MH; Lee WI; Chen LC; Lin SJ; Huang JL
    Acta Paediatr Taiwan; 1999; 40(3):182-5. PubMed ID: 10910611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.